Sam Altman-backed AI biotech announces $1 billion for its lofty goal: adding 10 years to human life span
Retro Biosciences will back clinical trials for three drugs—including a potential Alzheimer’s disease treatment set to begin ...
Sam Altman’s World now wants to link AI agents to your digital identity
OpenAI CEO Sam Altman took the technology world by surprise on Thursday with the release of Operator, his company's first AI ...
Sam Altman Is Beating Elon Musk at His Own Game, and It’s Honestly Brilliant
Since then, Musk hasn’t hidden his anger with Altman and OpenAI. He’s currently suing the company over its decision to become ...
eWeek5d
Sam Altman’s AI Briefing: Super-Agents To Revolutionize Software, Finance, and More
OpenAI CEO Sam Altman will brief U.S. officials on super-agents—AI systems set to revolutionize software development, finance ...
Sam Altman tells AI fans to lower their expectations as rumors swirl OpenAI is on the brink of superintelligence
Sam Altman has told OpenAI fans to lower their expectations after rumors the company had achieved AGI went viral on X.
Bret Baier Interviews Masa Son, Sam Altman, Larry Ellison: "We Have To Do The Big Investment For The Good Of Humanity"
OpenAI CEO Sam Altman, Oracle founder Larry Ellison and SoftBank CEO Masayoshi Son comment on President Trump’s Stargate AI ...
Sam Altman reportedly backs $1B round for AI healthcare startup Retro Biosciences
Retro Biosciences Inc., a startup using artificial intelligence to discover new drugs, is reportedly raising $1 billion in ...
OpenAI launches Operator, an AI agent that performs tasks autonomously
OpenAI announced that it is launching a research preview of Operator, an AI agent that can take control of a browser and perform tasks.